These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Penetration of antibiotics into respiratory secretions. Pennington JE Rev Infect Dis; 1981; 3(1):67-73. PubMed ID: 7013001 [TBL] [Abstract][Full Text] [Related]
25. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808 [TBL] [Abstract][Full Text] [Related]
26. Novel antibiotic combinations proposed for treatment of El-Halfawy OM; Naguib MM; Valvano MA Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272 [TBL] [Abstract][Full Text] [Related]
27. [Antibiotic treatment of lung disease in cystic fibrosis]. Biasini GC; Pistocchi E; Miano A Pediatr Med Chir; 1983; 5(4):157-60. PubMed ID: 6647075 [TBL] [Abstract][Full Text] [Related]
28. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis. Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508 [TBL] [Abstract][Full Text] [Related]
29. [Infections of the lower respiratory tract--effectiveness of beta- lactam antibiotics on bacterial isolates from sputum and bronchial secretions]. Kapfhammer G; Drlicek M; Vetter N Prax Klin Pneumol; 1988 Jul; 42(7):592-3. PubMed ID: 3186666 [No Abstract] [Full Text] [Related]
30. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782 [TBL] [Abstract][Full Text] [Related]
31. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]
32. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection]. Mordasini C; Aebischer CC; Schoch OD Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818 [TBL] [Abstract][Full Text] [Related]
33. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase). Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442 [TBL] [Abstract][Full Text] [Related]
35. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations. Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337 [TBL] [Abstract][Full Text] [Related]
36. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Soler N; Esperatti M; Ewig S; Huerta A; Agustà C; Torres A Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352 [TBL] [Abstract][Full Text] [Related]
37. [Bacterial infections and resistance to antibiotics in cystic fibrosis]. Taccetti G; Repetto T; Procopio E; Marianelli L; Campana S Pediatr Med Chir; 1999; 21(5 Suppl):213-8. PubMed ID: 10963010 [TBL] [Abstract][Full Text] [Related]
38. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Tunney MM; Field TR; Moriarty TF; Patrick S; Doering G; Muhlebach MS; Wolfgang MC; Boucher R; Gilpin DF; McDowell A; Elborn JS Am J Respir Crit Care Med; 2008 May; 177(9):995-1001. PubMed ID: 18263800 [TBL] [Abstract][Full Text] [Related]
39. [Chronic bronchitis: when are antibiotics indicated?]. Gerber AU Ther Umsch; 1992 Oct; 49(10):692-6. PubMed ID: 1440437 [TBL] [Abstract][Full Text] [Related]
40. Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototype. Kearns GL; Trang JM J Pediatr; 1986 May; 108(5 Pt 2):847-53. PubMed ID: 3517272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]